SBI-0206965 - Moligand™, ≥98% , Inhibitor of unc-51 like autophagy activating kinase 1, CAS No.1884220-36-3, Inhibitor of unc-51 like autophagy activating kinase 1

CAS: 1884220-36-3 Cat. No.: S413863 Summenformel: C21H21BrN4O5 Molekulargewicht: 489.32 EG-Nummer: 861-948-6 PubChem CID: 92044402
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
2-(5-Bromo-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-yloxy)-N-methylbenzamide|4-oxocyclohexylcarboxylic acid ethyl ester|SBI 0206965|2-((5-Bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide|Sbi0206965|SBI-0206965|SBI0206965; SBI 0206965|2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-N-methylbenzamide|2-[5-bromo-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxy-N-methylbenzamide|2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-N-methylbenzene-1-carboximidic acid|2-[[5-Bromo-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]oxy]-N-methyl-benzamide
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Größe
Deutschland (EU)
USA*
Preis
Menge
5mg
S413863-5mg
—
5 Auf Lager
109,25€
10mg
S413863-10mg
—
5 Auf Lager
175,20€
25mg
S413863-25mg
—
4 Auf Lager
351,35€
50mg
S413863-50mg
—
4 Auf Lager
562,21€
100mg
S413863-100mg
—
4 Auf Lager
890,21€
Enter a quantity for the sizes you want to add.

Übersicht

Information

SBI-0206965 SBI-0206965 is a highly selective autophagy kinase ULK1 inhibitor with IC50 of 108 nM, about 7-fold selectivity over ULK2. SBI-0206965 inhibits autophagy and enhances apoptosis in human glioblastoma and lung cancer cells.


Targets

ULK1 (Cell-free assay); ULK2 (Cell-free assay) 108 nM; 711 nM


In vitro

In HEK293T transfected with WT or KI Myc-tagged ULK1 and WT Vps34, SBI-0206965 inhibits Ser249 phosphorylation of overexpressed Vps34 and Beclin1 Ser15 phosphorylation. SBI-0206965 suppresses autophagy induced by mTOR inhibition in A549 cells, and prevents ULK1-dependent cell survival in WT MEFs. In addition, SBI-0206965 also synergizes with mTOR inhibition to induce cancer cell death.

Spezifikationen

Synonyme
2-(5-Bromo-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-yloxy)-N-methylbenzamide | 4-oxocyclohexylcarboxylic acid ethyl ester | SBI 0206965 | 2-((5-Bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide | Sbi0206965 | SBI-0206965 | SBI0206965; SBI 0206965 | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}ox Show more
Spezifikationen & Reinheit
Moligand™, ≥98%
Biochemische und physiologische Mechanismen
SBI-0206965 is a highly selective autophagy kinase ULK1 inhibitor with IC50 of 108 nM, about 7-fold selectivity over ULK2. SBI-0206965 inhibits autophagy and enhances apoptosis in human glioblastoma and lung cancer cells.
Storage
Store at -20°C
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
INHIBITOR
Mechanismus der Wirkung
Inhibitor of unc-51 like autophagy activating kinase 1
Reinheit
≥98%
Produkteigenschaften
ALogP
4.128
HBD-Zahl
2
Rotationsfähige Bindung
8
Namen und Kennungen
Pubchem Sid
SMILES
CNC(=O)C1=CC=CC=C1OC2=NC(=NC=C2Br)NC3=CC(=C(C(=C3)OC)OC)OC
IUPAC Name
2-[5-bromo-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxy-N-methylbenzamide
InChIKey
NEXGBSJERNQRSV-UHFFFAOYSA-N
InChI
1S/C21H21BrN4O5/c1-23-19(27)13-7-5-6-8-15(13)31-20-14(22)11-24-21(26-20)25-12-9-16(28-2)18(30-4)17(10-12)29-3/h5-11H,1-4H3,(H,23,27)(H,24,25,26)
Isomere SMILES
CNC(=O)C1=CC=CC=C1OC2=NC(=NC=C2Br)NC3=CC(=C(C(=C3)OC)OC)OC
PubChem CID
92044402
Molekulargewicht
489.32

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic oxygen compounds
KlasseOrganooxygen compounds
SubclassEthers
Intermediate Tree Nodes Not available
Direct ParentDiarylethers
Alternative Parents Benzamides  Methoxyanilines  Anisoles  Phenoxy compounds  Benzoyl derivatives  Methoxybenzenes  Alkyl aryl ethers  Aminopyrimidines and derivatives  Halopyrimidines  Aryl bromides  Heteroaromatic compounds  Secondary carboxylic acid amides  Azacyclic compounds  Organic oxides  Organobromides  Amines  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Diaryl ether - Benzamide - Benzoic acid or derivatives - Methoxyaniline - Phenoxy compound - Anisole - Methoxybenzene - Aniline or substituted anilines - Benzoyl - Phenol ether - Alkyl aryl ether - Aminopyrimidine - Halopyrimidine - Aryl bromide - Aryl halide - Monocyclic benzene moiety - Benzenoid - Pyrimidine - Heteroaromatic compound - Carboxamide group - Secondary carboxylic acid amide - Carboxylic acid derivative - Organoheterocyclic compound - Azacycle - Hydrocarbon derivative - Organic oxide - Amine - Organic nitrogen compound - Organohalogen compound - Organobromide - Organonitrogen compound - Aromatic heteromonocyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups.
External Descriptors Not available
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
ULK1 Tchem Serine/threonine-protein kinase ULK1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ULK2 Tchem Serine/threonine-protein kinase ULK2 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ULK2 Tchem Serine/threonine-protein kinase ULK2 (652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

10 results found

Lot NumberCertificate TypeDatumArtikel
D2312677D2312677Certificate of AnalysisJan 21, 2026 S413863
D2313474D2313474Certificate of AnalysisJan 21, 2026 S413863
D2313476D2313476Certificate of AnalysisJan 21, 2026 S413863
D2313477D2313477Certificate of AnalysisJan 21, 2026 S413863
D2313478D2313478Certificate of AnalysisJan 21, 2026 S413863
D2313479D2313479Certificate of AnalysisJan 21, 2026 S413863
D2313481D2313481Certificate of AnalysisJan 21, 2026 S413863
D2313482D2313482Certificate of AnalysisJan 21, 2026 S413863
D2313483D2313483Certificate of AnalysisJan 21, 2026 S413863
D2313484D2313484Certificate of AnalysisJan 21, 2026 S413863
Chemische und physikalische Eigenschaften
LöslichkeitSolubility (25°C) In vitro DMSO: 97 mg/mL (198.23 mM); Ethanol: 20 mg/mL warmed with 50ºC Water: bath (40.87 mM); Water: Insoluble;
DMSO (mg/ml) Maximale Löslichkeit97
DMSO (mM) Maximale Löslichkeit198.2342843
Wasser (mg/ml) Maximale Löslichkeit<1
Molekulargewicht489.3
XLogP33.800
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count8
Exact Mass488.07 Da
Monoisotopic Mass488.07 Da
Topological Polar Surface Area104.000 Ų
Heavy Atom Count31
Formal Charge0
Complexity560.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sicherheit und Gefahren (GHS)
Piktogramm(e)
Signal
Warning
Gefahrenhinweise

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Sicherheitshinweise

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P321:Specific treatment (see ... on this label).

P302+P352:IF ON SKIN: wash with plenty of water.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P362+P364:Take off contaminated clothing and wash it before reuse.

P405:Store locked up.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P501:Dispose of contents/container to an approved waste disposal plant.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

Citations of This Product
Lösungsrechner
Bewertungen

Kundenbewertungen

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.